Assessing The Likely Cost-Utility Of Alemtuzumab Versus Rabbit Anti-Thymocte Globulin As Induction Therapy For High-Risk Kidney Transplant Recipients

May 1, 2014, 00:00
10.1016/j.jval.2014.03.1709
https://www.valueinhealthjournal.com/article/S1098-3015(14)01760-4/fulltext
Title : Assessing The Likely Cost-Utility Of Alemtuzumab Versus Rabbit Anti-Thymocte Globulin As Induction Therapy For High-Risk Kidney Transplant Recipients
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01760-4&doi=10.1016/j.jval.2014.03.1709
First page : A294
Section Title : Urinary/Kidney Disorders
Open access? : No
Section Order : 1207
Categories :
Tags :
Regions :
ViH Article Tags :